Press Release-Nanjing Immunophage Biotech Co.,Ltd

CN

Mar 13, 2023

Immunophage Biotech Co., Ltd has successfully completed the first phase of Series B1 financing with nearly 200 million RMB
Jan 28, 2022

Immunophage Achieves 6 INDs for Solid Tumors and Autoimmune Diseases in Six Months

1

上一页 1/1 下一页

About
Pipeline
- IPG1094 IPGA09
- IPG7236 IPGA06
- IPG0521 IPGA17
- IPG11406 IPG017
- IPG8294 IPG023
- IPG6620 IPGA12
Publications
- Paper
- Patent
News
- Press Release
- Media Reports
Careers
- Join Us

Cpyright © 2023 Nanjing Immunophage Biotech Co.,Ltd All Rights Reserved.